On July 2, 2024, the U.S. Economic Development Administration (EDA) announced $49 million in Phase 2 funding to the Wisconsin Biohealth Tech Hub, a groundbreaking initiative set to drive transformative medical innovation, workforce development and critical job growth across Wisconsin.
The University of Wisconsin–Madison, one of 18 members of the Biohealth Tech Hub consortium, was a key partner in the effort. Selected from a highly competitive pool of applicants, the designation showcased an unprecedented scale of collaboration between industry, higher education, government and other stakeholders.
The consortium previously received Phase I designation as a regional technology and innovation hub by the EDA last fall. Led by BioForward, the state association representing Wisconsin’s bioscience industry, the Phase 2 proposal was recognized by the EDA for its ability to create new workforce opportunities while facilitating access to new medical innovations.